ATE210449T1 - Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards - Google Patents

Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards

Info

Publication number
ATE210449T1
ATE210449T1 AT92912078T AT92912078T ATE210449T1 AT E210449 T1 ATE210449 T1 AT E210449T1 AT 92912078 T AT92912078 T AT 92912078T AT 92912078 T AT92912078 T AT 92912078T AT E210449 T1 ATE210449 T1 AT E210449T1
Authority
AT
Austria
Prior art keywords
composition
myocardial reperfusion
reperfusion damage
reducing myocardial
adenosine
Prior art date
Application number
AT92912078T
Other languages
English (en)
Inventor
Mervyn B Forman
Edwin K Jackson
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Application granted granted Critical
Publication of ATE210449T1 publication Critical patent/ATE210449T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Dental Preparations (AREA)
AT92912078T 1991-05-22 1992-03-26 Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards ATE210449T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/704,058 US5206222A (en) 1991-05-22 1991-05-22 Methods for the reduction of myocardial reperfusion injury
PCT/US1992/002528 WO1992020346A1 (en) 1991-05-22 1992-03-26 Method and composition to reduce myocardial reperfusion injury

Publications (1)

Publication Number Publication Date
ATE210449T1 true ATE210449T1 (de) 2001-12-15

Family

ID=24827883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912078T ATE210449T1 (de) 1991-05-22 1992-03-26 Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards

Country Status (7)

Country Link
US (1) US5206222A (de)
EP (1) EP0589964B1 (de)
JP (1) JPH06510751A (de)
AT (1) ATE210449T1 (de)
CA (1) CA2103458C (de)
DE (1) DE69232287T2 (de)
WO (1) WO1992020346A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
CA2299320A1 (en) * 1997-09-22 1999-04-01 Item Development Ab New method of treatment
EP1021195A1 (de) * 1997-10-07 2000-07-26 The Regents Of The University Of California Behandlung okklusiver peripheral-gefässkrankheiten und koronarkrankheiten mit kombinationen aus heparin und adenosin-a2-agonisten, oder mit adenosin
US6015384A (en) * 1998-08-31 2000-01-18 Acuson Corporation Ultrasonic system and method for tissue viability imaging
JP4949558B2 (ja) * 1999-03-23 2012-06-13 ハイバーネーション・セラピューティクス・グローバル・リミテッド 臓器の停止、保護、及び保存
US6368573B1 (en) * 1999-11-15 2002-04-09 King Pharmaceuticals Research And Development, Inc. Diagnostic uses of 2-substituted adenosine carboxamides
US6599283B1 (en) * 2001-05-04 2003-07-29 Cv Therapeutics, Inc. Method of preventing reperfusion injury
DE10258770B4 (de) * 2001-12-18 2005-02-10 F. Hoffmann-La Roche Ag Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen
AUPS312602A0 (en) * 2002-06-21 2002-07-18 James Cook University Organ arrest, protection, preservation and recovery
AU2003291847B2 (en) * 2002-12-23 2010-12-02 Hibernation Therapeutics, A Kf Llc Organ preconditioning, arrest, protection, preservation and recovery
WO2004056180A1 (en) * 2002-12-23 2004-07-08 Global Cardiac Solutions Pty Ltd Organ preconditioning, arrest, protection, preservation and recovery (1)
US7423144B2 (en) * 2004-05-26 2008-09-09 Inotek Pharmaceuticals Corporation Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof
US20110076255A1 (en) * 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
BRPI0619261A2 (pt) * 2005-11-30 2011-09-27 Inotek Pharmaceuticals Corp derivados de purina e métodos de uso desses
JP2009538834A (ja) 2006-05-29 2009-11-12 ハイバーネイション セラピューティクス リミテッド 組織維持の改善
AU2007278754B2 (en) 2006-07-25 2014-11-13 Hibernation Therapeutics, A Kf Llc Trauma therapy
AU2008222595B2 (en) 2007-03-02 2014-03-27 Hibernation Therapeutics, A Kf Llc Transplants
WO2008134740A1 (en) * 2007-04-30 2008-11-06 The Trustees Of The University Of Pennsylvania System and method of resuscitation of a mammal
US20090136460A1 (en) * 2007-07-10 2009-05-28 Vanderbilt University Use of adenosine receptor ligands to promote cell adhesion in cell-based therapies
AU2008280836A1 (en) * 2007-07-25 2009-01-29 Hibernation Therapeutics, A Kf Llc Improved organ protection, preservation and recovery
US20090218349A1 (en) * 2008-02-29 2009-09-03 Silgan Containers Corporation Vacuum container with protective features
LT2523669T (lt) 2010-01-11 2017-04-25 Inotek Pharmaceuticals Corporation Akispūdžio mažinimo būdas, derinys ir rinkinys
AU2011230580A1 (en) 2010-03-26 2012-10-11 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
PL2807178T3 (pl) 2012-01-26 2017-12-29 Inotek Pharmaceuticals Corporation Bezwodne polimorfy azotanu (2R,3S,4R,5R)-5-(6-(cyklopentyloamino)-9H-puryn-9-ylo)-3,4-dihydroksytetrahydrofuran-2-ylo)metylu i sposoby ich wytwarzania
WO2014152723A1 (en) 2013-03-15 2014-09-25 Inotek Pharmaceuticals Corporation Ophthalmic formulations
AU2014292826A1 (en) 2013-07-17 2016-02-04 Hibernation Therapeutics, A Kf Llc A method for treating infection, sepsis and injury

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
EP0263071B1 (de) * 1986-09-30 1992-08-12 Ciba-Geigy Ag 2-Substituierte-e-kondensierte[1,2,4]Triazolo-[1,5-c]pyrimidine, pharmazeutische Zubereitungen und ihre Verwendung
EP0267878A1 (de) * 1986-11-14 1988-05-18 Ciba-Geigy Ag N9-Cyclopentylsubstituierte Adeninderivate
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
JPH0725785B2 (ja) * 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物

Also Published As

Publication number Publication date
DE69232287D1 (de) 2002-01-24
WO1992020346A1 (en) 1992-11-26
JPH06510751A (ja) 1994-12-01
EP0589964A1 (de) 1994-04-06
CA2103458A1 (en) 1992-11-23
US5206222A (en) 1993-04-27
CA2103458C (en) 2000-11-14
DE69232287T2 (de) 2002-07-25
EP0589964A4 (en) 1994-05-25
EP0589964B1 (de) 2001-12-12

Similar Documents

Publication Publication Date Title
DE69232287D1 (de) Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards
ATE188341T1 (de) Konservierungsmittel und verfahren zur behandlung von holz
RU93048466A (ru) Применение бензотиофенов для профилактики и лечения остеопороза и фармацевтическая композиция на их основе
ATE110958T1 (de) Verwendung von sertralin zur behandlung verfrühter ejakulation.
BR9304988A (pt) Composições auto-dispersáveis em água contendo organopolissiloxano e processo para o tratamento de madeira
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
DE69328186D1 (de) Zusammensetzung zur behandlung der parkinson-krankheit
ATE331515T1 (de) Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen
FI831230L (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
CO5050298A1 (es) Metodo y composicion para tratar impotencia
DE3650620D1 (de) Behandlungsverfahren kataboler dysfunktion
ATE394104T1 (de) Adenosin a2a rezeptor-antagonisten zur behandlung und vorbeugung von leberfibrose, zirrhose und fettleber
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE69113221D1 (en) Antiatherosclerotische und antithrombotische 2-amino-6-phenyl-4h-pyran-4-one.
EP1037918A4 (de) Verfahren und zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
UA50728C2 (uk) Спосіб стимуляції імунної системи за допомогою димеру лізоциму
ATE158287T1 (de) Derivate von 2,3-dihydro-2,2,4,6,7-pentaalkyl-5- benzofuranen
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
DE3864615D1 (de) Verfahren und anordnung zur behandlung von bei verbrennung schadstoffe freisetzendem holz, bzw. holzkohle.
HUT62474A (en) Process for producing veterinary composition with antiparasitic effect
DE59303164D1 (de) Wässrige Zusammensetzung zum Vorgerben von Hautblössen
BR8205141A (pt) Composicao acaricida e processo para tratamento de infestacoes de acaros em plantas uteis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee